{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:00:24Z","timestamp":1793714424509,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.ajo.2005.03.058","type":"journal-article","created":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T15:54:58Z","timestamp":1123170898000},"page":"407.e1-407.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Prophylaxis for Second Eye Involvement in Leber Hereditary Optic Neuropathy: An Open-Labeled, Nonrandomized Multicenter Trial of Topical Brimonidine Purite"],"prefix":"10.1016","volume":"140","author":[{"given":"Nancy J.","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Biousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley K.","family":"Farris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Lesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger E.","family":"Turbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuankuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Keaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2005.03.058_bib1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0002-9394(14)76784-4","article-title":"The clinical characteristics of pedigrees of Leber\u2019s hereditary optic neuropathy with the 11778 mutation","volume":"111","author":"Newman","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/brain\/118.2.319","article-title":"The clinical features of Leber\u2019s hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation","volume":"118","author":"Riordan-Eva","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.ajo.2005.03.058_bib3","first-page":"96","article-title":"Clinical features of Japanese Leber\u2019s hereditary optic neuropathy with 11778 mutation of mitochondrial DNA","volume":"39","author":"Hotta","year":"1995","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00041327-200212000-00001","article-title":"From genotype to phenotype in Leber hereditary optic neuropathy","volume":"22","author":"Newman","year":"2002","journal-title":"J Neuro-ophthalmol"},{"issue":"Suppl","key":"10.1016\/j.ajo.2005.03.058_bib5","first-page":"300","article-title":"Leber\u2019s disease","volume":"21","author":"Lundsgaard","year":"1944","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00573524","article-title":"Leber\u2019s disease in the Netherlands","volume":"17","author":"Van Senus","year":"1963","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1022694131572","article-title":"Mitochondrial implication in accidental and programmed cell death","volume":"29","author":"Zamzami","year":"1997","journal-title":"J Bioenergetics Biomemb"},{"key":"10.1016\/j.ajo.2005.03.058_bib8","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1074\/jbc.M110119200","article-title":"Cells bearing mutations causing Leber\u2019s hereditary optic neuropathy are sensitized to fas-induced apoptosis","volume":"277","author":"Danielson","year":"2002","journal-title":"J Biological Chemistry"},{"key":"10.1016\/j.ajo.2005.03.058_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1196\/annals.1299.037","article-title":"Apoptotic cell death of cybrid cells bearing Leber\u2019s hereditary optic neuropathy mutations is caspase independent","volume":"1010","author":"Zanna","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ajo.2005.03.058_bib10","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1074\/jbc.M210285200","article-title":"Leber\u2019s hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium","volume":"278","author":"Ghelli","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajo.2005.03.058_bib11","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/jnnp.2003.024372","article-title":"Cell response to oxidative stress induced apoptosis in patients with Leber\u2019s hereditary optic neuropathy","volume":"75","author":"Battisti","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajo.2005.03.058_bib12","first-page":"65","article-title":"Alpha-2-adenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration","volume":"40","author":"Yoles","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2005.03.058_bib13","first-page":"2849","article-title":"Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension","volume":"42","author":"WoldeMussie","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2005.03.058_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0952523802191152","article-title":"Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat","volume":"19","author":"Lai","year":"2002","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.ajo.2005.03.058_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0014-4886(03)00298-X","article-title":"Transient ischemia of the retina results in massive degeneration of the retinotectal projection","volume":"184","author":"Aviles-Trigueros","year":"2003","journal-title":"Exp Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2005.03.058_bib16","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0039-6257(03)00004-3","article-title":"Role of alpha-2 agonists in neuroprotection","volume":"48","author":"Wheeler","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/bjo.87.12.1463","article-title":"Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma","volume":"87","author":"Evans","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib18","unstructured":"Ferencz JR, Giladi G, Harel O, Belkin M, Assia EI. Topical brimonidine reduces collateral damage caused by laser photocoagulation for choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol. Forthcoming."},{"issue":"Suppl 3","key":"10.1016\/j.ajo.2005.03.058_bib19","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1016\/S0039-6257(01)00207-7","article-title":"Maintaining mitochondrial membrane impermeability","volume":"45","author":"Tatton","year":"2001","journal-title":"Sur Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9394(82)90197-0","article-title":"New Visual acuity charts for clinical research","volume":"94","author":"Ferris","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0161-6420(00)00654-0","article-title":"Vitreous concentration of topically applied brimonidine tartrate 0.2%","volume":"108","author":"Kent","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.03.058_bib22","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1523\/JNEUROSCI.16-19-05986.1996","article-title":"Alpha 2-adrenergic agonists include basic fibroblastic growth factor expression in photoreceptors in vivo and ameliorate light damage","volume":"6","author":"Wen","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajo.2005.03.058_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0006-8993(01)02759-7","article-title":"Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure","volume":"913","author":"Ahmed","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.ajo.2005.03.058_bib24","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","article-title":"Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis","volume":"270","author":"Xia","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ajo.2005.03.058_bib25","doi-asserted-by":"crossref","first-page":"24101","DOI":"10.1074\/jbc.272.39.24101","article-title":"BH3 domain of BAD is required for heterodimerization with BCL-X and pro-apoptotic activity","volume":"272","author":"Zha","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajo.2005.03.058_bib26","first-page":"397","article-title":"Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals","volume":"12","author":"Ballif","year":"2001","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.ajo.2005.03.058_bib27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/119.5.1481","article-title":"A case-control study of Leber\u2019s hereditary optic neuropathy","volume":"119","author":"Chalmers","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.ajo.2005.03.058_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0002-9394(03)00099-0","article-title":"Extensive investigation of a large Brazilian pedigree with 11778\/haplogroup J Leber hereditary optic neuropathy","volume":"136","author":"Sadun","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0002-9394(00)00603-6","article-title":"A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy","volume":"130","author":"Kerrison","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/brain\/102.3.559","article-title":"Leber\u2019s optic neuropathy. A clinical and visual evoked potential study of affected and asymptomatic members of a six generation family","volume":"102","author":"Carroll","year":"1979","journal-title":"Brain"},{"key":"10.1016\/j.ajo.2005.03.058_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ajo.2003.08.010","article-title":"Ophthalmologic findings in a large pedigree of 11778\/haplogroup J Leber hereditary optic neuropathy","volume":"137","author":"Sadun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/bjo.79.5.442","article-title":"Evidence for preserved direct pupillary light response in Leber\u2019s hereditary optic neuropathy","volume":"79","author":"Wakakura","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib33","first-page":"2528","article-title":"Comparing pupil function with visual function in patients with Leber\u2019s hereditary optic neuropathy","volume":"40","author":"Bremner","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2005.03.058_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s004170050220","article-title":"Pupillary light reflexes in patients with Leber\u2019s hereditary optic neuropathy","volume":"237","author":"Ludtke","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9394(98)00152-4","article-title":"Relative afferent papillary defects in patients with Leber hereditary optic neuropathy and unilateral visual loss","volume":"126","author":"Jacobson","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.03.058_bib36","series-title":"La Maladie de Leber. Etude Clinique et G\u00e9n\u00e9tique \u00e0 Propos de 86 Cas Examin\u00e9s.","author":"Asseman","year":"1958"},{"key":"10.1016\/j.ajo.2005.03.058_bib37","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1167\/iovs.02-0864","article-title":"Optic neuropathy induced by reductions in mitochondrial superoxide dismutase","volume":"44","author":"Qi","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2005.03.058_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.20175","article-title":"SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I","volume":"56","author":"Qi","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajo.2005.03.058_bib39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ana.10354","article-title":"Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy","volume":"52","author":"Guy","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajo.2005.03.058_bib40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1359-6446(03)03000-9","article-title":"Interrupting apoptosis in neurodegenerative disease","volume":"9","author":"Waldmeier","year":"2004","journal-title":"Drug Discov Today"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939405004083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939405004083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:50:20Z","timestamp":1757595020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939405004083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0002939405004083"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2005.03.058","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylaxis for Second Eye Involvement in Leber Hereditary Optic Neuropathy: An Open-Labeled, Nonrandomized Multicenter Trial of Topical Brimonidine Purite","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2005.03.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}